Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
Low-temperature plasma has been studied for medical applications. We had focused on the plasma cancer treatments, and we have previously invented plasma-activated solutions. In this study, we used plasma-activated medium (PAM) and plasma-activated Ringer’s lactate solution (PAL) for plasma cancer treatments. We found that PAM induced oxidative stress-dependent cell death on glioblastoma brain tumor cells while PAL induced oxidative stress-independent cell death on glioblastoma cells. These results suggest that plasma-activated solutions might be useful for cancer drug resistant cancer therapy.
|